文献速递心脏核医学肿瘤 PET/CT

18F-NaF在亚临床主动脉瓣钙化中摄取的临床意义:与冠状动脉粥样硬化的关系及预测价值

Clinical implications of 18F-sodium fluoride uptake in subclinical aortic valve calcification: Its relation to coronary atherosclerosis and its predictive value.
PubMed 文献 · J Nucl Cardiol · 2019-09-03

本研究纳入25例CT检出亚临床主动脉瓣钙化(AVC)及冠状动脉斑块并接受18F-NaF PET/CT的患者,发现AVC的TBRmax与CT钙化参数正相关,高危冠脉斑块患者AVC的TBRmax更高,且AVC的TBRmax与随访AVC评分增加正相关。提示18F-NaF PET可能提供亚临床AVC分子状态及进展的新信息。

要点

  • AVC的18F-NaF摄取与CT钙化参数正相关。
  • 高危冠脉斑块患者AVC的TBRmax显著更高。
  • AVC的TBRmax与随访AVC评分增加正相关。

核心结论

  • 18F-NaF PET与CT数据提示亚临床AVC的钙化活性与冠状动脉粥样硬化特征相关。
  • 18F-NaF PET可能提供亚临床AVC分子状态及未来进展的新信息。

研究设计与样本

  • 研究纳入25例CT检出亚临床AVC及冠状动脉斑块并接受18F-NaF PET/CT的患者。
  • 在CT上评估每例患者的AVC评分、体积、平均密度及高危冠脉斑块存在情况。
  • 用最大组织本底比(TBRmax)定量AVC及冠脉斑块的局灶18F-NaF摄取。

主要发现

  • AVC的TBRmax(A-TBRmax)与CT上AVC参数呈正相关。
  • 14例高危冠脉斑块患者A-TBRmax显著高于无此类斑块者(1.60 ± 0.18 vs 1.42 ± 0.13,P = 0.012)。
  • A-TBRmax与每例患者冠脉斑块最大TBRmax正相关(r = 0.55,P = 0.0043)。
  • 11例接受随访CT者的A-TBRmax与随后AVC评分增加正相关(r = 0.74,P = 0.0091)。

临床怎么用

  • 对CT检出亚临床AVC及冠脉斑块者,可考虑18F-NaF PET/CT评估钙化活性。
  • AVC的18F-NaF摄取增高可能提示合并高危冠脉斑块及AVC未来进展风险。

局限性

  • 样本量小(25例,随访CT仅11例)。
  • 为单中心观察性研究,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uptake of 18F-sodium fluoride (18F-NaF) on positron emission tomography (PET) reflects active calcification. Application of this technique in the early phase of aortic valve calcification (AVC) is of clinical interest. We investigated clinical implications of 18F-NaF uptake in subclinical AVC evaluated simultaneously with coronary atherosclerosis, and the utility of 18F-NaF uptake in predicting AVC progression. METHODS: We studied 25 patients with subclinical AVC and coronary plaques detected on computed tomography (CT) who underwent 18F-NaF PET/CT. AVC score, volume, mean density, and the presence of high-risk coronary plaque were evaluated on CT in each patient. Focal 18F-NaF uptake in AVC and in coronary plaques was quantified with the maximum tissue-to-background ratio (TBRmax). RESULTS: There were positive correlations between AVC TBRmax (A-TBRmax) and AVC parameters on CT. The 14 patients with high-risk coronary plaque had significantly higher A-TBRmax than those without such plaque (1.60 ± 0.18 vs 1.42 ± 0.13, respectively; P = 0.012). A-TBRmax positively correlated with maximum TBRmax of coronary plaque per patient (r = 0.55, P = 0.0043). In the 11 patients who underwent follow-up CT scan, A-TBRmax positively correlated with subsequent increase in AVC score (r = 0.74, P = 0.0091). CONCLUSION: Our 18F-NaF PET- and CT-based data indicate relationships between calcification activity in subclinical AVC and characteristics of coronary atherosclerosis. 18F-NaF PET may provide new information regarding molecular conditions and future progression of subclinical AVC.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Nakamoto Y, Kitagawa T, Sasaki K, et al. Clinical implications of 18F-sodium fluoride uptake in subclinical aortic valve calcification: Its relation to coronary atherosclerosis and its predictive value. J Nucl Cardiol. 2019. PMID: 31482532. doi:10.1007/s12350-019-01879-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。